Thomas Adocker

For more than twenty years, Thomas has been advising national and international clients in the field of intellectual property, with a strong focus on patent law, in particular with respect to litigation, licensing and technology transfer. Thomas has established an excellent reputation for representing clients in major Austrian patent infringement cases, especially in the pharmaceutical and medical device sectors and is known for his broad know-how in connection with multinational disputes.

In addition to his extensive regulatory expertise, Thomas is also frequently active in franchise law and deals with distribution agreements.

Show full CV Hide full CV

Career

2023	Partner, Taylor Wessing
2006 - 2023	Partner, Schwarz Schönher Attworneys at law
2001 - 2005	Associate, Engin-Deniz Attorneys at law

2000 - 2001

Legal trainee, Higher Regional Court of Vienna

More Less

Education

2005	Austrian Bar exam, Vienna
2000	Summer Term, Miami University, Oxford/Ohio, USA
1996 – 2000	Legal studies, University of Vienna

Publications

Contribution on the commentary by Stadler/Koller on the Austrian Patent Act (1^st ed. July 2019, 2^nd ed. forthcoming): incl. commentary on the elements of infringement and the provisions on the statute of limitations

Contribution to the textbook by Hüttermann "Einheitspatent und Einheitliches Patentgericht" (1^st ed. Dec 2016, 2^nd ed. forthcoming): Presentation of the Austrian legal situation and the differences to the Unified Patent Court System

Contribution on the commentary by Hüpfauf/Koller on the Austrian Medical Devices Act (1^st edition forthcoming, expected 2024): Distinction between Medical Devices Act and Blood Regulatory Rules

Zivilrechtliche Hausdurchsuchung und Beweissicherung nach Enforcement Directive und § 151b PatG (ecolex 2020, 669)

Zur Zulässigkeit der Einschränkung eines Patents durch Aufnahme von Merkmalen aus dessen Beschreibung in den Anspruch (OPM, Op 1/13 – ÖBl-LS 2014/20)

Zum Ersatz von Kosten der patentanwaltlichen Vertretung und Gutachtenserstellung im Patentverletzungsverfahren (OLG Wien, 15 R 109/12b – ÖBl-LS 2013/18)

Zur Zulässigkeit eines in Österreich nicht rezeptpflichtigen Medikaments (OGH 4 Ob 13/12h – Arzneimittel-Versandhandel II – ÖBl 2012/65)

Zur Zulässigkeit der Erteilung eines ergänzenden Schutzzertifikats (EuGH C-427/09, ÖBl-LS 2011/117)

Österreichischer Oberster Patent- und Markensenat trifft Grundsatzentscheidung zum Verhältnis zwischen der Erfindungshöhe eines Patents und eines Gebrauchsmusters (OPM, OGM 1/10 – Teleskopausleger, GRUR Int 2011, 673)

Nichtigkeit eines ergänzenden Schutzzertifikats und dessen Geltendmachung (OGH, 17 Ob 6/10x – Memantin, GRUR Int 2011, 385)

Vermögenswerte Interessen aus dem Namensrecht (OGH, 17 Ob 2/10h – Maria Treben, ecolex 2010/438)